VRDN Latest Quarter’s Earnings
Announce Date11/4/2026
EPS Actual (USD)-0.89
Revenue Actual (USD)25.75M
This page offers detailed Viridian Therapeutics Inc earnings data including the latest Viridian Therapeutics Inc earnings report, the upcoming Viridian Therapeutics Inc earnings date, historical data and Viridian Therapeutics Inc earnings call news.
| Release Date | Period End | EPS/Forecast | Revenue/Forecast | EPS Surprise % | Revenue Surprise % |
|---|---|---|---|---|---|
| 11/4/2026 | 09/2026 | -0.89/-0.97 | 25.75M/5.08M | 7.89% | 406.58% |
| 8/6/2026 | 06/2026 | -1.18/-1.03 | 284.00K/22.31K | -14.48% | 1172.97% |
| 5/5/2026 | 03/2026 | -1.03/-1.09 | 141.00K/27.50K | 6.22% | 412.73% |
| 2/26/2026 | 12/2025 | -1.27/-1.07 | 132.00K/12.73M | -19.15% | -98.96% |
| 11/5/2025 | 09/2025 | -0.42/-1.08 | 70.57M/33.91K | 60.93% | 208009.70% |
| 8/6/2025 | 06/2025 | -1.23/-1.01 | 75.00K/43.64K | -22.31% | 71.86% |
| 5/6/2025 | 03/2025 | -1.07/-0.97 | 72.00K/70.13K | -10.48% | 2.67% |
| 2/27/2025 | 12/2024 | -0.99/-1.04 | 72.00K/44.50K | 3.91% | 61.80% |
Viridian Therapeutics (VRDN) Q3 2026 Earnings Call: Lumvoa Revenue Reaches $24.7 Million